AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $315,656 | +200.6% | 74,800 | +43.0% | 0.01% | +200.0% |
| Q3 2022 | $105,000 | +38.2% | 52,300 | +187.4% | 0.00% | +33.3% |
| Q1 2022 | $76,000 | -41.1% | 18,200 | -32.1% | 0.00% | -62.5% |
| Q4 2021 | $129,000 | +43.3% | 26,800 | +58.6% | 0.01% | +14.3% |
| Q3 2021 | $90,000 | – | 16,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $144,839,000 | 11.40% |
| Eversept Partners, LP | 4,755,480 | $32,004,380 | 2.41% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $109,116,000 | 1.27% |
| EAM Global Investors LLC | 365,719 | $2,461,000 | 0.68% |
| Signature Wealth Management Partners, LLC | 87,666 | $590,000 | 0.57% |
| Jackson Creek Investment Advisors LLC | 221,043 | $1,488,000 | 0.52% |
| Tranquilli Financial Advisor LLC | 71,414 | $481,000 | 0.39% |
| Hillsdale Investment Management Inc. | 611,200 | $4,113,000 | 0.34% |
| EAM Investors, LLC | 259,873 | $1,749,000 | 0.26% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 180,000 | $1,211,000 | 0.25% |